Epidermal growth factor polymorphism (rs4444903) predicts hepatocellular carcinoma in Egyptian population

Rasha Fathy, Shaden Muawia, Moustafa Sakr, Mohamed Elshal

Open source

DOI
10.21608/rjab.2019.273778
Published
2019-12-31
Container
Research Journal of Applied Biotechnology
Publisher
Egypts Presidential Specialized Council for Education and Scientific Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21608/rjab.2019.273778,
  title = {Epidermal growth factor polymorphism (rs4444903) predicts hepatocellular carcinoma in Egyptian population},
  author = {Rasha Fathy and Shaden Muawia and Moustafa Sakr and Mohamed Elshal},
  year = {2019},
  journal = {Research Journal of Applied Biotechnology},
  doi = {10.21608/rjab.2019.273778},
  url = {https://doi.org/10.21608/rjab.2019.273778}
}

RIS

TY  - JOUR
TI  - Epidermal growth factor polymorphism (rs4444903) predicts hepatocellular carcinoma in Egyptian population
AU  - Rasha Fathy
AU  - Shaden Muawia
AU  - Moustafa Sakr
AU  - Mohamed Elshal
PY  - 2019
JO  - Research Journal of Applied Biotechnology
DO  - 10.21608/rjab.2019.273778
UR  - https://doi.org/10.21608/rjab.2019.273778
ER  - 

APA

Fathy, R., Muawia, S., Sakr, M., & Elshal, M. (2019). Epidermal growth factor polymorphism (rs4444903) predicts hepatocellular carcinoma in Egyptian population. Research Journal of Applied Biotechnology. https://doi.org/10.21608/rjab.2019.273778

Source records